We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+11.5%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.62B
AUM Growth
-$62.4M
Cap. Flow
-$203M
Cap. Flow %
-12.53%
Top 10 Hldgs %
11.78%
Holding
792
New
346
Increased
157
Reduced
185
Closed
89

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$9.44M
2
LOW icon
Lowe's Companies
LOW
+$9.42M
3
EA icon
Electronic Arts
EA
+$9.24M
4
ALXN
Alexion Pharmaceuticals
ALXN
+$9M
5
COST icon
Costco
COST
+$8.92M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$46.2M
2
ABBV icon
AbbVie
ABBV
+$29.9M
3
BMY icon
Bristol-Myers Squibb
BMY
+$27.4M
4
EBAY icon
eBay
EBAY
+$20.5M
5
TEAM icon
Atlassian
TEAM
+$19.1M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 18.44%
3 Consumer Discretionary 15.45%
4 Industrials 9.36%
5 Financials 8.57%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RACE icon
1
Ferrari
RACE
$63.3B
$38.7M 2.38%
232,917
+2,239
+1% +$362K
HUM icon
2
Humana
HUM
$46.7B
$34M 2.1%
92,801
-17,303
-16% -$5.49M
CGNX icon
3
Cognex
CGNX
$10.3B
$23.6M 1.45%
420,602
-53,604
-11% -$2.77M
EOG icon
4
EOG Resources
EOG
$78B
$19.9M 1.23%
237,915
-137,948
-37% -$10.1M
NBIS
5
Nebius Group N.V.
NBIS
$47.7B
$13.6M 0.84%
312,515
+94,215
+43% +$3.51M
ALNY icon
6
Alnylam Pharmaceuticals
ALNY
$36.3B
$13.5M 0.83%
117,013
-5,100
-4% -$508K
TER icon
7
Teradyne
TER
$54.8B
$12.3M 0.76%
180,763
-11,937
-6% -$758K
CME icon
8
CME Group
CME
$92.2B
$12M 0.74%
60,004
+4
+0% +$821
MA icon
9
Mastercard
MA
$477B
$12M 0.74%
40,100
-4,107
-9% -$1.16M
PFE icon
10
Pfizer
PFE
$140B
$11.5M 0.71%
309,560
+32,902
+12% +$1.17M
A icon
11
Agilent Technologies
A
$39.1B
$11.3M 0.7%
132,508
-11
-0% -$866
VTRS icon
12
Viatris
VTRS
$20.1B
$11.2M 0.69%
559,581
+73,381
+15% +$1.37M
REGN icon
13
Regeneron Pharmaceuticals
REGN
$68.8B
$10.9M 0.67%
29,001
-5,404
-16% -$1.82M
INCY icon
14
Incyte
INCY
$23.5B
$10.8M 0.67%
123,625
+1,925
+2% +$164K
BMY icon
15
Bristol-Myers Squibb
BMY
$127B
$10.8M 0.66%
167,703
-478,197
-74% -$27.4M
ZTS icon
16
Zoetis
ZTS
$31.6B
$10.7M 0.66%
80,931
-50,727
-39% -$6.3M
NKE icon
17
Nike
NKE
$61.9B
$10.7M 0.66%
105,605
-54
-0.1% -$5.09K
MU icon
18
Micron Technology
MU
$1.04T
$10.6M 0.66%
+197,601
New +$9.44M
PH icon
19
Parker-Hannifin
PH
$125B
$10.6M 0.65%
51,508
-4,301
-8% -$833K
FTI icon
20
TechnipFMC
FTI
$30.6B
$10.6M 0.65%
662,592
+129,169
+24% +$2M
MNST icon
21
Monster Beverage
MNST
$91.4B
$10.5M 0.65%
331,800
-2
-0% -$59
DPZ icon
22
Domino's
DPZ
$11B
$10.5M 0.65%
35,816
+3,205
+10% +$883K
ROP icon
23
Roper Technologies
ROP
$36.3B
$10.5M 0.65%
29,700
+4,500
+18% +$1.55M
IQV icon
24
IQVIA
IQV
$34.7B
$10.5M 0.65%
68,000
– –
DXCM icon
25
DexCom
DXCM
$27.6B
$10.2M 0.63%
187,200
-174,828
-48% -$8.29M
1
2 3 4 5

Similar funds

ISS
Intesa Sanpaolo SpA. Turin, Italy $1.69B AUM
GAM
Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return
BCM
BlueCrest Capital Management St Helier, Jersey $1.69B AUM 20.01% 1-Year Est. Return
FACM
Forest Avenue Capital Management Miami, Florida $1.69B AUM 104.84% 1-Year Est. Return
TCBWMS
Texas Capital Bank Wealth Management Services Dallas, Texas $1.68B AUM 21.72% 1-Year Est. Return
WAS
Wesleyan Assurance Society Birmingham, United Kingdom $1.69B AUM 28.38% 1-Year Est. Return
SGI
Summit Global Investments Bountiful, Utah $1.69B AUM 12.13% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

PDT Partners's Q4 2019 Portfolio in Review

As of Q4 2019, PDT Partners held 792 positions worth $1.62B, down 3.7% from $1.68B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

PDT Partners withdrew a net $203M in Q4 2019, closing 89 positions and reducing 185 holdings. Its most notable exit was Linde, an estimated $46.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 25% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PDT Partners opened a new position in Micron Technology worth $10.6M.

  • PDT Partners's largest Q4 2019 buy was Micron Technology: 197,601 shares worth $10.6M.
  • PDT Partners added most to Bausch Health in Q4 2019, an estimated $5.3M increase.
  • PDT Partners's biggest Q4 2019 reduction was AbbVie, cutting an estimated $29.9M.
  • PDT Partners fully exited Linde in Q4 2019, selling an estimated $46.2M.
  • PDT Partners's ten largest holdings make up 12% of its $1.62B portfolio in Q4 2019.
  • PDT Partners opened 346 new positions and closed 89 in Q4 2019.
  • PDT Partners's portfolio value fell 3.7% quarter-over-quarter to $1.62B.

Based on PDT Partners's 13F filing for Q4 2019, filed 14 Feb 2020.